Investor Relations

Subscribe to our News Dispatch Service

* indicates required



Latest Press Releases

Sernova-HemAcure Consortium to Present Achievements in Development of a Regenerative Medicine Approach to Treat Hemophilia A / October 23, 2018


Sernova Completes Oversubscribed Private Placement of $2,754,000 / July 23, 2018


Sernova Announces $2,000,000 First Closing of Private Placement / July 16, 2018

All Press Releases →


Latest Updates


2018 Financial Report - 3rd Quarter - July 31, 2018 / September 28, 2018


2018 Management Discussion & Analysis (MD&A) - 3rd Quarter - July 31, 2018 / September 28, 2018


2018 Financial Report - 2nd Quarter - / July 18, 2018


2018 Management Discussion & Analysis (MD&A) - 2nd Quarter - / June 29, 2018


Corporate Presentation - April 2018 / May 28, 2018


2018 Financial Report - 1st Quarter - / March 29, 2018


2018 Management Discussion & Analysis (MD&A) - 1st Quarter - / March 29, 2018


Clearance by FDA of Sernova's US IND - Conference call audio recording / December 11, 2017

All Updates →

    Back to Videos

    2018 Management Discussion & Analysis (MD&A) - 1st Quarter


    2018 / Mar 29




    Latest Updates

    September 28, 2018

    2018 Financial Report - 3rd Quarter

    July 31, 2018

    Open

    September 28, 2018

    2018 Management Discussion & Analysis (MD&A) - 3rd Quarter

    July 31, 2018

    Open

    July 18, 2018

    2018 Financial Report - 2nd Quarter

    Open

    June 29, 2018

    2018 Management Discussion & Analysis (MD&A) - 2nd Quarter

    Open

    May 28, 2018

    Corporate Presentation

    April 2018

    Open

    March 29, 2018

    2018 Financial Report - 1st Quarter

    Open

    March 29, 2018

    2018 Management Discussion & Analysis (MD&A) - 1st Quarter

    Open

    December 11, 2017

    Clearance by FDA of Sernova's US IND

    Conference call audio recording

    Open

    September 11, 2017

    Sernova Fact Sheet

    Open

    AGM Documents

    Please download the related documents

    2018 Sernova AGM Circular document

    PDF file

    Open

    2018 Sernova AGM Proxy document

    PDF file

    Open

    Corporate Governance

    Please read the related documents

    Insider Trading Compliance Policy

    PDF file

    Open

    Whistleblower Policy

    PDF file

    Open

    Analyst Coverage

    Sernova and its securities are covered by the following investment firms. This list of investment firms is being provided solely for your information and convenience and does not constitute an endorsement of or concurrence with any information, opinions, estimates, forecasts or recommendations provided by any of the investment firms listed below by Sernova. Furthermore, Sernova does not distribute information or reports prepared by analysts. The following list includes analysts currently known by Sernova Corp. to follow the company but may not be complete or up to date and may change without notice. Sernova undertakes no obligation to update and maintain this list. Please refer to the Legal Notice on this website for further information.



    Analyst

    Douglas Loe

    Firm

    Echelon Wealth Partners

    Phone

    1-888-216-9779 ext 501

    Stock Price

    SVA chart by TradingView

    Please Note: All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Sernova nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.